Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06971991 · ClinicalTrials.gov registry record · NA
qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver
A NA study of Transarterial Embolism and Transarterial Chemoembolization, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06971991 is a NA study of Transarterial Embolism and Transarterial Chemoembolization that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06971991, a NA study of Transarterial Embolism and Transarterial Chemoembolization, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver transarterial embolization is a way of treating liver tumors by blocking blood flow to it. The qDSA technique could help doctors ensure the blood flow to the tumor is decreased by the right amount by calculating blood flow before, during, and after the procedure. Up to 20 participants will be enrolled for 1 study visit and data collection for up to 6 months.
Conditions Studied
Interventions
- DEVICE qDSA Blood Flow Measurement
Study Locations (1)
Wisconsin
- UW Hospital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06971991
The ClinicalTrials.gov registry entry for NCT06971991 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Transarterial Embolism appearing as the primary indexed condition, and to 1 intervention - of which qDSA Blood Flow Measurement is the first listed.
NCT06971991 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06971991 about?
NCT06971991 is a clinical study titled "qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver". The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver transarterial embolization is a way of treating liver tumors by blocking blood flow to it. The qDSA technique could help...
What is the current status of trial NCT06971991?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-03-13. Estimated completion is 2026-12.
What conditions does trial NCT06971991 study?
This clinical trial studies the following conditions: Transarterial Embolism, Transarterial Chemoembolization.
What interventions are being tested in trial NCT06971991?
The interventions under investigation include: qDSA Blood Flow Measurement (DEVICE).
Who is sponsoring clinical trial NCT06971991?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06971991 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.